$12.5B revenue (2025), Jersey City) spun from Johnson & Johnson in 2023 and operates consumer health brands including Listerine, Flonase, and Optrex across oral care, respiratory health, and wound care. Kimberly-Clark acquisition announced in 2026 consolidates two major consumer health portfolios.
Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.
Notes, edits, or content requests — sent directly to James.